Calogero V.
- Country
- Italy
- Department
- Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 7 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating Acute Myeloid Leukemia (AML), with particular emphasis on developing therapeutic strategies for different patient populations.
- NPM1-mutated AML treatment
- Relapsed/refractory AML management
- Elderly AML patient care
Their research encompasses novel therapeutic approaches including targeted treatments and chemotherapy-free combinations.
Novel Therapeutic Approaches
The investigator focuses on evaluating innovative treatment combinations, including eltanexor and the Venetoclax-Decitabine combination therapy.
- Targeted molecular therapies
- Chemotherapy-free regimens
- Treatment safety assessment
Their work includes evaluation of antileukemic activity and treatment tolerability in various patient subgroups.
Transplantation Medicine
The investigator studies treatment pathways leading to allogeneic stem cell transplantation in AML patients.
- Pre-transplant therapy optimization
- Age-specific treatment strategies
- Response assessment criteria
Their research examines specific age groups and their eligibility for transplantation following various treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.